Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.
Colgate University’s Picker Art Gallery will open its spring exhibition A Thought Is A Thread: Contemporary Artists Reworking ...
Stifel lowered the firm’s price target on Colgate-Palmolive (CL) to $93 from $95 and keeps a Hold rating on the shares. Following “mixed” 2024 ...
In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...
Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.
"Our (sales) guidance includes the impact of the planned exit from private label pet nutrition over the course of 2025," said ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
NEW YORK – Procter and Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and mouth rinse for young children because the products contain ...